Merck and Pfizer decline vs the broader market as results released [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
But shares of Merck & Co. and Pfizer bucked the trend, with Merck falling 1% and Pfizer falling almost 5% The culprit? Solid but unspectacular results as tech and gold rally. Still, together, their earnings give us a pretty good read on the pharmaceutical sector and the broader economy. For Merck, fourth-quarter worldwide sales rose 5% to $16.4 billion , or 4% excluding currency effects, while full-year revenue topped $65 billion. Oncology remained the backbone of the business, with Keytruda sales climbing 7% to nearly $32 billion for the year — nearly half Merck's total annual revenue —pointing to its status as one of the world's most important cancer drugs even as Merck prepares for eventual loss of exclusivity later this decade. What could replace such a huge chunk of overall sales? Merck highlighted growing contributions from newer therapies. Winrevair, a hypertension drug, generated $1.4 billion in sales in its first year, while pneumococcal vaccine Capvaxix brought in just
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms [MSNBC.com]MSNBC.com
- Merck's (NYSE:MRK) Q4 CY2025 Sales Beat Estimates [Yahoo! Finance]Yahoo! Finance
- China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® [Yahoo! Finance]Yahoo! Finance
- Earnings Snapshot: Merck tops Q4, issues weaker-than-expected FY profit and sales outlook [Seeking Alpha]Seeking Alpha
- Merck in Charts: Q4 sees pharmaceutical sales up ~6% Y/Y, led by 7% rise in KEYTRUDA [Seeking Alpha]Seeking Alpha
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/3/26 - Form 8-K
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- MRK's page on the SEC website